PecFent accepted in Scotland for treatment of breakthrough cancer pain

Published January 18, 2011

PecFent accepted in Scotland for treatment of breakthrough cancer pain
Archimedes Pharma Ltd., a leading international specialty pharma company, today announced the decision by the Scottish Medicines Consortium to accept PecFent for use within NHS Scotland. PecFent is indicated for the treatment of breakthrough pain in adults who are already receiving maintenance opioid therapy for chronic cancer pain.
Read more on News-Medical-Net

Success of BASICS alcohol program uncertain
After about 20 years of changing and re-naming alcohol intervention programs, the university initiated a new program for the fall 2010 semester –– but BASICS’s effectiveness is still unclear.
Read more on Penn State Collegian

New bill proposes prescription requirement for cold meds
BELL COUNTY— A bill set to go before the Kentucky legislature could make cold medicine a controlled substance.
Read more on The Middlesboro Daily